Thr2-Amyloid Beta Peptide (1-42)

The A2T Icelandic amyloid beta 1-42 variant, which is studied for altered processing, aggregation and disease-protective behavior.

Amyloid aggregation kinetics, APP mutation research, oligomerization, fibril morphology and neuroprotection studies.

This sequence-defined peptide is intended for research use. Confirm solubility, storage, concentration and assay controls for the intended experimental system. The supplied material is not intended for diagnostic or therapeutic use.